TP53 and B-cell chronic lymphocytic leukemia: In chronic lymphocytic leukemia (CLL) low expression of miR-34a was found in chemotherapy-refractory disease associated with deletion of the p53 gene, which results in decreased DNA damage response and apoptosis resistance [72].